Trial Profile
Pharmacokinetic interactions between elvitegravir, atazanavir/ritonavir and telaprevir in volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Mar 2015
Price :
$35
*
At a glance
- Drugs Elvitegravir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors Gilead Sciences
- 06 Mar 2015 New trial record